483
Comparative Biosciences, IncComparative Biosciences, Inc – FDA 483, Jul 30, 2024
Record Details
An FDA inspection of Comparative Biosciences, Inc. in Sunnyvale, CA, revealed significant Good Laboratory Practice (GLP) deficiencies. Observations included failures to properly document protocol changes, provide adequate separate laboratory space for BSL-2 studies, and ensure equipment was adequately inspected, cleaned, and maintained with appropriate records. These issues compromise study integrity and biosafety.
View Company Profile
ID · 17ad7641-5177-4b8d-8995-fa0ea23668a8
Other documents for Comparative Biosciences, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.